Your browser doesn't support javascript.
loading
Evaluation of the Geographical Accessibility of Genome-Matched Clinical Trials on a National Experience.
Crimini, Edoardo; Tini, Giulia; Tarantino, Paolo; Ascione, Liliana; Repetto, Matteo; Beria, Paolo; Ranghiero, Alberto; Marra, Antonio; Belli, Carmen; Criscitiello, Carmen; Esposito, Angela; Guerini Rocco, Elena; Barberis, Massimo C P; Mazzarella, Luca; Curigliano, Giuseppe.
Afiliação
  • Crimini E; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy.
  • Tini G; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
  • Tarantino P; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy.
  • Ascione L; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy.
  • Repetto M; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
  • Beria P; Breast Oncology Center, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Ranghiero A; Harvard Medical School, Boston, MA, USA.
  • Marra A; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy.
  • Belli C; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
  • Criscitiello C; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy.
  • Esposito A; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
  • Guerini Rocco E; Department of Architettura e Studi Urbani, Politecnico di Milano, Milan, Italy.
  • Barberis MCP; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy.
  • Mazzarella L; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy.
  • Curigliano G; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy.
Oncologist ; 29(2): 159-165, 2024 Feb 02.
Article em En | MEDLINE | ID: mdl-37669224
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2024 Tipo de documento: Article